Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy

Immunity

Volumn 47, Issue 4, 2017, Pages 789-802.e9

  Glodde, Nicole ^a,b   Bald, Tobias ^a,b,c   van den Boorn Konijnenberg, Debby ^b   Nakamura, Kyohei ^c   O'Donnell, Jake S ^c,d   Szczepanski, Sabrina ^b   Brandes, Maria ^b   Eickhoff, Sarah ^b   Das, Indrajit ^c   Shridhar, Naveen ^a,b   Hinze, Daniel ^b   Rogava, Meri ^a,b   van der Sluis, Tetje C ^a,b   Ruotsalainen, Janne J ^a,b   Gaffal, Evelyn ^a,b   Landsberg, Jennifer ^b   Ludwig, Kerstin U ^b   Wilhelm, Christoph ^b   Riek Burchardt, Monika ^a   Müller, Andreas J ^a,e   Gebhardt, Christoffer ^f   Scolyer, Richard A ^g,h   Long, Georgina V ^h   Janzen, Viktor ^b   Teng, Michele W L ^c,d   Kastenmüller, Wolfgang ^b   Mazzone, Massimiliano ^i,j   Smyth, Mark J ^c,d   Tüting, Thomas ^a,b   Hölzel, Michael ^b   more..

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^h UNIVERSITY OF SYDNEY   (Australia)

ⁱ DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^j UNIVERSITY OF LEUVEN   (Belgium)

more..

Author keywords

bone marrow; c MET; cancer immunotherapy; HGF; lymph node; melanoma; neutrophils; plasticity; T cells; therapy resistance

Indexed keywords

CAPMATINIB; PROTEIN TYROSINE KINASE; SCATTER FACTOR RECEPTOR; GAMMA INTERFERON;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CELL EXPANSION; CONTROLLED STUDY; EFFECTOR CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; LYMPH NODE; LYMPHOCYTIC INFILTRATION; MELANOMA; MOUSE; NEUTROPHIL; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; IMMUNOTHERAPY; KAPLAN MEIER METHOD; KNOCKOUT MOUSE; METABOLISM; NEOPLASMS, EXPERIMENTAL; PROCEDURES; TRANSGENIC MOUSE; TUMOR CELL LINE; TUMOR MICROENVIRONMENT;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOTHERAPY; INTERFERON-GAMMA; KAPLAN-MEIER ESTIMATE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL; NEUTROPHILS; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR MICROENVIRONMENT;

EID: 85032788807     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2017.09.012     Document Type: Article

References (64)

1. Baek, J.-H., Birchmeier, C., Zenke, M., Hieronymus, T., The HGF receptor/Met tyrosine kinase is a key regulator of dendritic cell migration in skin immunity. J. Immunol. 189 (2012), 1699–1707.
2. Bald, T., Quast, T., Landsberg, J., Rogava, M., Glodde, N., Lopez-Ramos, D., Kohlmeyer, J., Riesenberg, S., van den Boorn-Konijnenberg, D., Hömig-Hölzel, C., et al. Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma. Nature 507 (2014), 109–113.
3. Bald, T., Landsberg, J., Lopez-Ramos, D., Renn, M., Glodde, N., Jansen, P., Gaffal, E., Steitz, J., Tolba, R., Kalinke, U., et al. Immune cell-poor melanomas benefit from PD-1 blockade after targeted type I IFN activation. Cancer Discov. 4 (2014), 674–687.
4. Benci, J.L., Xu, B., Qiu, Y., Wu, T.J., Dada, H., Twyman-Saint Victor, C., Cucolo, L., Lee, D.S.M., Pauken, K.E., Huang, A.C., et al. Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade. Cell 167 (2016), 1540–1554.
5. Benkhoucha, M., Santiago-Raber, M.-L., Schneiter, G., Chofflon, M., Funakoshi, H., Nakamura, T., Lalive, P.H., Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 107 (2010), 6424–6429.
6. Blaisdell, A., Crequer, A., Columbus, D., Daikoku, T., Mittal, K., Dey, S.K., Erlebacher, A., Neutrophils oppose uterine epithelial carcinogenesis via debridement of hypoxic tumor cells. Cancer Cell 28 (2015), 785–799.
7. Bowers, N.L., Helton, E.S., Huijbregts, R.P.H., Goepfert, P.A., Heath, S.L., Hel, Z., Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway. PLoS Pathog., 10, 2014, e1003993.
8. Campbell, E.L., Bruyninckx, W.J., Kelly, C.J., Glover, L.E., McNamee, E.N., Bowers, B.E., Bayless, A.J., Scully, M., Saeedi, B.J., Golden-Mason, L., et al. Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. Immunity 40 (2014), 66–77.
9. Chtanova, T., Schaeffer, M., Han, S.-J., van Dooren, G.G., Nollmann, M., Herzmark, P., Chan, S.W., Satija, H., Camfield, K., Aaron, H., et al. Dynamics of neutrophil migration in lymph nodes during infection. Immunity 29 (2008), 487–496.
10. Coffelt, S.B., Kersten, K., Doornebal, C.W., Weiden, J., Vrijland, K., Hau, C.-S., Verstegen, N.J.M., Ciampricotti, M., Hawinkels, L.J.A.C., Jonkers, J., de Visser, K.E., IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature 522 (2015), 345–348.
11. Crompton, J.G., Sukumar, M., Roychoudhuri, R., Clever, D., Gros, A., Eil, R.L., Tran, E., Hanada, K., Yu, Z., Palmer, D.C., et al. Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics. Cancer Res. 75 (2015), 296–305.
12. Ebert, P.J.R., Cheung, J., Yang, Y., McNamara, E., Hong, R., Moskalenko, M., Gould, S.E., Maecker, H., Irving, B.A., Kim, J.M., et al. MAP kinase inhibition promotes T cell and anti-tumor activity in combination with PD-L1 checkpoint blockade. Immunity 44 (2016), 609–621.
13. Eickhoff, S., Brewitz, A., Gerner, M.Y., Klauschen, F., Komander, K., Hemmi, H., Garbi, N., Kaisho, T., Germain, R.N., Kastenmüller, W., Robust anti-viral immunity requires multiple distinct T cell-dendritic cell interactions. Cell 162 (2015), 1322–1337.
14. Eruslanov, E.B., Bhojnagarwala, P.S., Quatromoni, J.G., Stephen, T.L., Ranganathan, A., Deshpande, C., Akimova, T., Vachani, A., Litzky, L., Hancock, W.W., et al. Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J. Clin. Invest. 124 (2014), 5466–5480.
15. Ferrucci, P.F., Gandini, S., Battaglia, A., Alfieri, S., Di Giacomo, A.M., Giannarelli, D., Cappellini, G.C.A., De Galitiis, F., Marchetti, P., Amato, G., et al. Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients. Br. J. Cancer 112 (2015), 1904–1910.
16. Finisguerra, V., Di Conza, G., Di Matteo, M., Serneels, J., Costa, S., Thompson, A.A.R., Wauters, E., Walmsley, S., Prenen, H., Granot, Z., et al. MET is required for the recruitment of anti-tumoural neutrophils. Nature 522 (2015), 349–353.
17. Finisguerra, V., Prenen, H., Mazzone, M., Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma. Oncogene 35 (2016), 5457–5467.
18. Fridlender, Z.G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G.S., Albelda, S.M., Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN. Cancer Cell 16 (2009), 183–194.
19. Gabrilovich, D.I., Ostrand-Rosenberg, S., Bronte, V., Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12 (2012), 253–268.
20. Gebhardt, C., Sevko, A., Jiang, H., Lichtenberger, R., Reith, M., Tarnanidis, K., Holland-Letz, T., Umansky, L., Beckhove, P., Sucker, A., et al. Myeloid cells and related chronic inflammatory factors as novel predictive markers in melanoma treatment with ipilimumab. Clin. Cancer Res. 21 (2015), 5453–5459.
21. Gerrard, T.L., Cohen, D.J., Kaplan, A.M., Human neutrophil-mediated cytotoxicity to tumor cells. J. Natl. Cancer Inst. 66 (1981), 483–488.
22. Granot, Z., Henke, E., Comen, E.A., King, T.A., Norton, L., Benezra, R., Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell 20 (2011), 300–314.
23. Graveel, C.R., Tolbert, D., Vande Woude, G.F., MET: a critical player in tumorigenesis and therapeutic target. Cold Spring Harb. Perspect. Biol., 5, 2013, a009209.
24. Grenier, A., Chollet-Martin, S., Crestani, B., Delarche, C., El Benna, J., Boutten, A., Andrieu, V., Durand, G., Gougerot-Pocidalo, M.-A., Aubier, M., Dehoux, M., Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils. Blood 99 (2002), 2997–3004.
25. Hampton, H.R., Bailey, J., Tomura, M., Brink, R., Chtanova, T., Microbe-dependent lymphatic migration of neutrophils modulates lymphocyte proliferation in lymph nodes. Nat. Commun., 6, 2015, 7139.
26. Hasenberg, A., Hasenberg, M., Männ, L., Neumann, F., Borkenstein, L., Stecher, M., Kraus, A., Engel, D.R., Klingberg, A., Seddigh, P., et al. Catchup: a mouse model for imaging-based tracking and modulation of neutrophil granulocytes. Nat. Methods 12 (2015), 445–452.
27. Hattori, N., Mizuno, S., Yoshida, Y., Chin, K., Mishima, M., Sisson, T.H., Simon, R.H., Nakamura, T., Miyake, M., The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism. Am. J. Pathol. 164 (2004), 1091–1098.
28. Henry, C.M., Sullivan, G.P., Clancy, D.M., Afonina, I.S., Kulms, D., Martin, S.J., Neutrophil-derived proteases escalate inflammation through activation of IL-36 family cytokines. Cell Rep. 14 (2016), 708–722.
29. Hikono, H., Kohlmeier, J.E., Takamura, S., Wittmer, S.T., Roberts, A.D., Woodland, D.L., Activation phenotype, rather than central- or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells. J. Exp. Med. 204 (2007), 1625–1636.
30. Hölzel, M., Bovier, A., Tüting, T., Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?. Nat. Rev. Cancer 13 (2013), 365–376.
31. Huh, C.-G., Factor, V.M., Sánchez, A., Uchida, K., Conner, E.A., Thorgeirsson, S.S., Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc. Natl. Acad. Sci. USA 101 (2004), 4477–4482.
32. Jalili, A., Shirvaikar, N., Marquez-Curtis, L.A., Turner, A.R., Janowska-Wieczorek, A., The HGF/c-Met axis synergizes with G-CSF in the mobilization of hematopoietic stem/progenitor cells. Stem Cells Dev. 19 (2010), 1143–1151.
33. Kamenyeva, O., Boularan, C., Kabat, J., Cheung, G.Y.C., Cicala, C., Yeh, A.J., Chan, J.L., Periasamy, S., Otto, M., Kehrl, J.H., Neutrophil recruitment to lymph nodes limits local humoral response to Staphylococcus aureus. PLoS Pathog., 11, 2015, e1004827.
34. Kastenmüller, W., Torabi-Parizi, P., Subramanian, N., Lämmermann, T., Germain, R.N., A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell 150 (2012), 1235–1248.
35. Kohlmeyer, J., Cron, M., Landsberg, J., Bald, T., Renn, M., Mikus, S., Bondong, S., Wikasari, D., Gaffal, E., Hartmann, G., Tüting, T., Complete regression of advanced primary and metastatic mouse melanomas following combination chemoimmunotherapy. Cancer Res. 69 (2009), 6265–6274.
36. Landsberg, J., Kohlmeyer, J., Renn, M., Bald, T., Rogava, M., Cron, M., Fatho, M., Lennerz, V., Wölfel, T., Hölzel, M., Tüting, T., Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Nature 490 (2012), 412–416.
37. Laubach, V.E., Shesely, E.G., Smithies, O., Sherman, P.A., Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. USA 92 (1995), 10688–10692.
38. Law, C.W., Chen, Y., Shi, W., Smyth, G.K., voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol., 15, 2014, R29.
39. Liao, Y., Smyth, G.K., Shi, W., The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res., 41, 2013, e108.
40. Liu, X., Wang, Q., Yang, G., Marando, C., Koblish, H.K., Hall, L.M., Fridman, J.S., Behshad, E., Wynn, R., Li, Y., et al. A novel kinase inhibitor, INCB28060, blocks c-MET-dependent signaling, neoplastic activities, and cross-talk with EGFR and HER-3. Clin. Cancer Res. 17 (2011), 7127–7138.
41. Liu, J., Blake, S.J., Yong, M.C.R., Harjunpää H., Ngiow, S.F., Takeda, K., Young, A., O'Donnell, J.S., Allen, S., Smyth, M.J., Teng, M.W., Improved efficacy of neoadjuvant compared to adjuvant immunotherapy to eradicate metastatic disease. Cancer Discov. 6 (2016), 1382–1399.
42. Manz, M.G., Boettcher, S., Emergency granulopoiesis. Nat. Rev. Immunol. 14 (2014), 302–314.
43. Mishalian, I., Bayuh, R., Levy, L., Zolotarov, L., Michaeli, J., Fridlender, Z.G., Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression. Cancer Immunol. Immunother. 62 (2013), 1745–1756.
44. Nagato, T., Lee, Y.-R., Harabuchi, Y., Celis, E., Combinatorial immunotherapy of polyinosinic-polycytidylic acid and blockade of programmed death-ligand 1 induce effective CD8 T-cell responses against established tumors. Clin. Cancer Res. 20 (2014), 1223–1234.
45. Ngiow, S.F., Young, A., Jacquelot, N., Yamazaki, T., Enot, D., Zitvogel, L., Smyth, M.J., A threshold level of intratumor CD8+ T-cell PD1 expression dictates therapeutic response to anti-PD1. Cancer Res. 75 (2015), 3800–3811.
46. Nicolás-Ávila, J.Á., Adrover, J.M., Hidalgo, A., Neutrophils in homeostasis, immunity, and cancer. Immunity 46 (2017), 15–28.
47. Okunishi, K., Dohi, M., Nakagome, K., Tanaka, R., Mizuno, S., Matsumoto, K., Miyazaki, J., Nakamura, T., Yamamoto, K., A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J. Immunol. 175 (2005), 4745–4753.
48. Pekarek, L.A., Starr, B.A., Toledano, A.Y., Schreiber, H., Inhibition of tumor growth by elimination of granulocytes. J. Exp. Med. 181 (1995), 435–440.
49. Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S., Comoglio, P.M., Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3 (2003), 347–361.
50. Riesenberg, S., Groetchen, A., Siddaway, R., Bald, T., Reinhardt, J., Smorra, D., Kohlmeyer, J., Renn, M., Phung, B., Aymans, P., et al. MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment. Nat. Commun., 6, 2015, 8755.
51. Robinson, M.D., McCarthy, D.J., Smyth, G.K., edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26 (2010), 139–140.
52. Sagiv, J.Y., Michaeli, J., Assi, S., Mishalian, I., Kisos, H., Levy, L., Damti, P., Lumbroso, D., Polyansky, L., Sionov, R.V., et al. Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep. 10 (2015), 562–573.
53. Sarkar, S., Kalia, V., Haining, W.N., Konieczny, B.T., Subramaniam, S., Ahmed, R., Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205 (2008), 625–640.
54. Shen, M., Hu, P., Donskov, F., Wang, G., Liu, Q., Du, J., Tumor-associated neutrophils as a new prognostic factor in cancer: a systematic review and meta-analysis. PLoS ONE, 9, 2014, e98259.
55. Shojaei, F., Lee, J.H., Simmons, B.H., Wong, A., Esparza, C.O., Plumlee, P.A., Feng, J., Stewart, A.E., Hu-Lowe, D.D., Christensen, J.G., HGF/c-Met acts as an alternative angiogenic pathway in sunitinib-resistant tumors. Cancer Res. 70 (2010), 10090–10100.
56. Singhal, S., Bhojnagarwala, P.S., O'Brien, S., Moon, E.K., Garfall, A.L., Rao, A.S., Quatromoni, J.G., Stephen, T.L., Litzky, L., Deshpande, C., et al. Origin and role of a subset of tumor-associated neutrophils with antigen-presenting cell features in early-stage human lung cancer. Cancer Cell 30 (2016), 120–135.
57. Spitzer, M.H., Carmi, Y., Reticker-Flynn, N.E., Kwek, S.S., Madhireddy, D., Martins, M.M., Gherardini, P.F., Prestwood, T.R., Chabon, J., Bendall, S.C., et al. Systemic immunity is required for effective cancer immunotherapy. Cell 168 (2017), 487–502.
58. Templeton, A.J., McNamara, M.G., Šeruga, B., Vera-Badillo, F.E., Aneja, P., Ocaña, A., Leibowitz-Amit, R., Sonpavde, G., Knox, J.J., Tran, B., et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J. Natl. Cancer Inst., 106, 2014, dju124.
59. Tesio, M., Golan, K., Corso, S., Giordano, S., Schajnovitz, A., Vagima, Y., Shivtiel, S., Kalinkovich, A., Caione, L., Gammaitoni, L., et al. Enhanced c-Met activity promotes G-CSF-induced mobilization of hematopoietic progenitor cells via ROS signaling. Blood 117 (2011), 419–428.
60. Trusolino, L., Bertotti, A., Comoglio, P.M., MET signalling: principles and functions in development, organ regeneration and cancer. Nat. Rev. Mol. Cell Biol. 11 (2010), 834–848.
61. Voehringer, D., Koschella, M., Pircher, H., Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1). Blood 100 (2002), 3698–3702.
62. Wculek, S.K., Malanchi, I., Neutrophils support lung colonization of metastasis-initiating breast cancer cells. Nature 528 (2015), 413–417.
63. Yang, C.-W., Unanue, E.R., Neutrophils control the magnitude and spread of the immune response in a thromboxane A2-mediated process. J. Exp. Med. 210 (2013), 375–387.
64. Yang, C.-W., Strong, B.S.I., Miller, M.J., Unanue, E.R., Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants. J. Immunol. 185 (2010), 2927–2934.